Ludivine Petit

Title: Ludivine Petit: Innovator in Emergency Contraception

Introduction: Ludivine Petit is a notable inventor hailing from Embourg, Belgium. She has made significant contributions to the field of reproductive health through her innovative work, particularly in the area of emergency contraception. With one patent under her name, she stands out as a leading figure in her field.

Latest Patents: Ludivine Petit holds a patent for the use of estetrol as an emergency contraceptive. This patent describes a new application of tetrahydroxylated estrogens, specifically estetrol (1,3,5(10)-estratrien-3, 15α, 16α, 17β-tetrol). The invention outlines a method of emergency contraception that involves the oral administration of estetrol in a single dose within 120 hours following sexual intercourse. This breakthrough could potentially provide women with a reliable option in emergency situations.

Career Highlights: Ludivine Petit is currently associated with Estetra S.p.r.l., a company dedicated to developing innovative solutions in healthcare. Her career has been characterized by a commitment to advancing women's health, and her groundbreaking research is paving the way for new contraceptive options.

Collaborations: Throughout her career, Ludivine has collaborated with esteemed colleagues, including Wout Wouters and Herman Jan Tijmen Coelingh Bennink. These partnerships have been instrumental in enhancing her research and the development of her patented innovations.

Conclusion: Ludivine Petit exemplifies the spirit of innovation in the realm of reproductive health. Her work on estetrol as an emergency contraceptive not only demonstrates her expertise but also has the potential to significantly impact women's health choices. As she continues her career at Estetra S.p.r.l., the future of her inventions looks promising, paving new paths in the field of contraception.